Robert Michel
Until Robert L. Michel came along and founded The Dark Intelligence Group (DIG) two decades ago, the clinical laboratory industry and the anatomic pathology profession lacked a trustworthy source for information about the management and operations of medical laboratories. From its inception in 1995, The Dark Report quickly became the “go to” source of industry intelligence, innovations in lab management, and strategic market analysis.
This excellence in reporting has earned recognition from his peers. For example, twice Michel and The Dark Report have won national awards for best investigative reporting by the Specialty Information Publishers Association. In 2005, the award was for Michel’s coverage about how the anatomic pathology condominium laboratories (pod labs) operated by urologists and gastroenterologists came to be, who operated them, and how these owners marketed the AP condo labs to other physician groups. In 2009, Michel’s award for best investigative reporting resulted from his published interviews with Quest Diagnostics Incorporated when the company admitted that, for a period of 18 months, it had been reported inaccurate Vitamin 25(OH) D results because of problems with its laboratory-developed test methodology. The Dark Report’s story was picked up by The New York Times and was in the national news cycle for several days.
In his role as Editor-in-Chief, Michel brought unique capabilities to DIG and The Dark Report. His management training and diverse business experience—along with his skills as a concise writer and analyst—proved to be a winning combination for readers of The Dark Report. For that reason, Michel’s story has many intriguing elements.
Immediately prior to founding DIG, he had served in several executive positions for Nichols Institute based in Portland, Oregon, and San Juan Capistrano, California. This was during the time that Nichols Institute was an independent public lab company with annual revenues of about $280 million (prior to its acquisition by MetPath, Inc., now Quest Diagnostics Incorporated). He traveled extensively to many of the clinical lab business units owned by Nichols Institute in different regions of the United States and played a role in formulating effective market strategies in response to the emergence of closed-panel HMOs, capitated pricing, and full-risk managed care contracts, among other successful management initiatives.
Prior to his service at Nichols Institute, Michel served at three different Fortune 100 companies. These were Procter & Gamble, Centex Corporation, and Financial Corp. of America. Each was an opportunity to master new management techniques and apply them in different industries. Between these positions, he gained experience as an entrepreneur, having founded a real estate development firm and a general contracting company in the Southeastern United States.
Robert Michel earned a Bachelor of Arts degree in Economics at the University of California, Los Angeles, where he played rugby, a sport he participated in for another 22 years. He is a native of California and grew up in Santa Ana.
Articles by Robert Michel
Bi-Coastal Powerhouse Formed by Lab Merger
CEO SUMMARY: Changes to healthcare continue to stimulate responses from independent commercial laboratories. This time it’s a merger of Las Vegas-based Associated Pathologists Laboratories with American Medical Laboratories of Chantilly, Virginia. This combination creates the third-larg…
Finally: Respect for Cytyc As Aetna OKs ThinPrep®
CEO SUMMARY: Here’s an important development in the battle to get the healthcare community to accept new technology for the preparation of Pap smears. Aetna/U.S. Healthcare announced that it would cover the monolayer preparation tests offered by Cytyc and AutoCyte. Aetna’s decision ma…
Capitated Contracts Losing Favor Within the Hospital Industry
IT APPEARS THAT AN INCREASING number of hospitals in mature managed care markets like California and Colorado are rejecting capitated managed care contracts. If future events verify this trend, the experience of hospitals may demonstrate a way for clinical laboratories to reject capitated arrangemen…
Ten Management Myths Misled Clinical Laboratory Executives
CEO SUMMARY: We offer our second installment about the ten management myths which led the clinical laboratory industry astray during the 1980s and 1990s. Regretfully, clients responding to part one of this series tell us that these management myths remain alive and well—and continue to …
New Trend Threatens Pay For Pathology Part A Services
CEO SUMMARY: Each year, more hospitals adopt an aggressive stance and attempt to eliminate or greatly reduce the compensation paid to their pathology groups for Medicare Part A technical services. There is a surprising reason why an increasing number of hospital administrators suddenly ha…
Pathologist Income Symposium, Healtheon, Biogenetics, Healthworks Alliance
PATHOLOGIST INCOME SYMPOSIUM DATES ARE NOVEMBER 12-13, 1999 SCOTTSDALE IS AGAIN SLATED TO HOST the upcoming private Pathologist Income Symposium, scheduled for November 12-13, 1999. This year’s symposium tackles the toughest of all topics: increasing the compensation paid by hosp…
“September 20, 1999 Intelligence: Late Breaking Lab News”
Here’s an interesting company to keep an eye on. Abaton.com, based in Minneapolis, is one of the early entrants in the race to offer web-based clinical network solutions at the point of care. Centrex Clinical Laboratories, Inc. of Utica, New York is purchasing Abat…
Reference Labs Intensify Battle for Send-Out Tests
CEO SUMMARY: Expect a battle royale for hospital reference and esoteric testing by the handful of labs that offer such testing to hospitals throughout the country. With the merger of Quest Diagnostics Incorporated and SmithKline Beecham Clinical Laboratories now a fact, competitors are al…
Kaiser’s National Lab Business Awarded to American Medical Laboratories
MANY EXECUTIVES in the laboratory industry will be surprised to learn that American Medical Laboratories, Inc. (AML) of Chantilly, Virginia has aced out Quest Diagnostics Incorporated to become the primary reference laboratory for all divisions of Kaiser Perm…
Clinical Lab and Pathology Informatics Merging For Internet Solutions
CEO SUMMARY: Information is where both clinical laboratories and anatomic pathologists will continue to add value to healthcare in the future. At this year’s Executive War College in May, THE DARK REPORT asked several leading innovators in laboratory and pathology informatics to share t…
CURRENT ISSUE
Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.